{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:46:24Z","timestamp":1789163184102,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T00:00:00Z","timestamp":1618617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH-97N-1008"],"award-info":[{"award-number":["NTUH-97N-1008"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH-100-N1732"],"award-info":[{"award-number":["NTUH-100-N1732"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["NTUH-103-S2397"],"award-info":[{"award-number":["NTUH-103-S2397"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1007\/s00330-021-07923-9","type":"journal-article","created":{"date-parts":[[2021,4,17]],"date-time":"2021-04-17T04:02:54Z","timestamp":1618632174000},"page":"8040-8049","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Preoperative 2-[18F]FDG PET-CT aids in the prognostic stratification for patients with primary ampullary carcinoma"],"prefix":"10.1007","volume":"31","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3613-2756","authenticated-orcid":false,"given":"Pei-Ju","family":"Chuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu-Po","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Chang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wen","family":"Tien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shu","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Hung","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoh-Fang","family":"Yen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Lun","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Wen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9359-0606","authenticated-orcid":false,"given":"Mei-Fang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,17]]},"reference":[{"key":"7923_CR1","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.ejso.2018.02.008","volume":"44","author":"Z Jin","year":"2018","unstructured":"Jin Z, Hartgers ML, Sanhueza CT et al (2018) Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience. Eur J Surg Oncol 44:677\u2013683","journal-title":"Eur J Surg Oncol"},{"key":"7923_CR2","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1002\/jso.21374","volume":"100","author":"J Albores-Saavedra","year":"2009","unstructured":"Albores-Saavedra J, Schwartz AM, Batich K, Henson DE (2009) Cancers of the ampulla of vater: demographics, morphology, and survival based on 5,625 cases from the SEER program. J Surg Oncol 100:598\u2013605","journal-title":"J Surg Oncol"},{"key":"7923_CR3","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1111\/hpb.12038","volume":"15","author":"J Askew","year":"2013","unstructured":"Askew J, Connor S (2013) Review of the investigation and surgical management of resectable ampullary adenocarcinoma. HPB (Oxford) 15:829\u2013838","journal-title":"HPB (Oxford)"},{"key":"7923_CR4","doi-asserted-by":"crossref","unstructured":"Di Giorgio A, Alfieri S, Rotondi F et al (2005) Pancreatoduodenectomy for tumors of Vater\u2019s ampulla: report on 94 consecutive patients. World J Surg 29:513\u2013518","DOI":"10.1007\/s00268-004-7498-x"},{"key":"7923_CR5","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1097\/RLU.0b013e31829b266a","volume":"38","author":"MF Cheng","year":"2013","unstructured":"Cheng MF, Wang HP, Tien YW et al (2013) Usefulness of PET\/CT for the differentiation and characterization of periampullary lesions. Clin Nucl Med 38:703\u2013708","journal-title":"Clin Nucl Med"},{"key":"7923_CR6","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00259-014-2907-3","volume":"42","author":"HJ Choi","year":"2015","unstructured":"Choi HJ, Kang CM, Jo K et al (2015) Prognostic significance of standardized uptake value on preoperative (1)(8)F-FDG PET\/CT in patients with ampullary adenocarcinoma. Eur J Nucl Med Mol Imaging 42:841\u2013847","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7923_CR7","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/MPA.0000000000000313","volume":"44","author":"N Kawada","year":"2015","unstructured":"Kawada N, Uehara H, Hosoki T et al (2015) Usefulness of dual-phase 18F-FDG PET\/CT for diagnosing small pancreatic tumors. Pancreas 44:655\u2013659","journal-title":"Pancreas"},{"key":"7923_CR8","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/MNM.0000000000000178","volume":"35","author":"Y Xi","year":"2014","unstructured":"Xi Y, Guo R, Hu J, Zhang M, Zhang X, Li B (2014) 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer. Nucl Med Commun 35:1112\u20131118","journal-title":"Nucl Med Commun"},{"key":"7923_CR9","first-page":"173","volume":"43","author":"T Higashi","year":"2002","unstructured":"Higashi T, Saga T, Nakamoto Y et al (2002) Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. J Nucl Med 43:173\u2013180","journal-title":"J Nucl Med"},{"key":"7923_CR10","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/RLU.0b013e31823926c9","volume":"37","author":"AM Garcia Vicente","year":"2012","unstructured":"Garcia Vicente AM, Castrejon AS, Relea Calatayud F et al (2012) 18F-FDG retention index and biologic prognostic parameters in breast cancer. Clin Nucl Med 37:460\u2013466","journal-title":"Clin Nucl Med"},{"key":"7923_CR11","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00259-013-2343-9","volume":"40","author":"G Cheng","year":"2013","unstructured":"Cheng G, Torigian DA, Zhuang H, Alavi A (2013) When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET? Eur J Nucl Med Mol Imaging 40:779\u2013787","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7923_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1053\/j.semnuclmed.2017.02.009","volume":"47","author":"RV Parghane","year":"2017","unstructured":"Parghane RV, Basu S (2017) Dual-time point (18)F-FDG-PET and PET\/CT for differentiating benign from malignant musculoskeletal lesions: opportunities and limitations. Semin Nucl Med 47:373\u2013391","journal-title":"Semin Nucl Med"},{"key":"7923_CR13","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1097\/SLA.0000000000001182","volume":"262","author":"J Kwon","year":"2015","unstructured":"Kwon J, Kim BH, Kim K, Chie EK, Ha SW (2015) Survival benefit of adjuvant chemoradiotherapy in patients with ampulla of Vater cancer: a systematic review and meta-analysis. Ann Surg 262:47\u201352","journal-title":"Ann Surg"},{"key":"7923_CR14","first-page":"225","volume":"18","author":"S Junrungsee","year":"2017","unstructured":"Junrungsee S, Kittivarakul E, Ko-iam W, Lapisatepun W, Sandhu T, Chotirosniramit A (2017) Prognostic factors and survival of patients with carcinoma of the ampulla of Vater after pancreaticoduodenectomy. Asian Pac J Cancer Prev 18:225\u2013229","journal-title":"Asian Pac J Cancer Prev"},{"key":"7923_CR15","doi-asserted-by":"publisher","unstructured":"Moekotte AL, Lof S, Van Roessel S et al (2019) Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: international multicenter cohort study. Ann Surg. https:\/\/doi.org\/10.1097\/SLA.0000000000003177","DOI":"10.1097\/SLA.0000000000003177"},{"key":"7923_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/00000658-199807000-00013","volume":"228","author":"JR Howe","year":"1998","unstructured":"Howe JR, Klimstra DS, Moccia RD, Conlon KC, Brennan MF (1998) Factors predictive of survival in ampullary carcinoma. Ann Surg 228:87\u201394","journal-title":"Ann Surg"},{"key":"7923_CR17","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ et al (2015) FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging 42:328\u2013354","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"7923_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13550-016-0177-8","volume":"6","author":"A Sher","year":"2016","unstructured":"Sher A, Lacoeuille F, Fosse P et al (2016) For avid glucose tumors, the SUV peak is the most reliable parameter for [(18)F]FDG-PET\/CT quantification, regardless of acquisition time. EJNMMI Res 6:21","journal-title":"EJNMMI Res"},{"key":"7923_CR19","first-page":"1093","volume":"48","author":"J Li","year":"2014","unstructured":"Li J, Lu Z, Yan L et al (2014) Comparison of dietary survey, frequency and 24 hour urinary Na methods in evaluation of salt intake in the population. Zhonghua Yu Fang Yi Xue Za Zhi 48:1093\u20131097","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"7923_CR20","doi-asserted-by":"publisher","first-page":"3762651","DOI":"10.1155\/2017\/3762651","volume":"2017","author":"I Unal","year":"2017","unstructured":"Unal I (2017) Defining an optimal cut-point value in ROC Analysis: an alternative approach. Comput Math Methods Med 2017:3762651","journal-title":"Comput Math Methods Med"},{"key":"7923_CR21","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/modpathol.3880238","volume":"13","author":"M Takashima","year":"2000","unstructured":"Takashima M, Ueki T, Nagai E et al (2000) Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions. Mod Pathol 13:1300\u20131307","journal-title":"Mod Pathol"},{"key":"7923_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/SLA.0000000000001999","volume":"267","author":"A Mafficini","year":"2018","unstructured":"Mafficini A, Amato E, Cataldo I et al (2018) Ampulla of Vater carcinoma: sequencing analysis identifies TP53 status as a novel independent prognostic factor and potentially actionable ERBB, PI3K, and WNT pathways gene mutations. Ann Surg 267:149\u2013156","journal-title":"Ann Surg"},{"key":"7923_CR23","first-page":"209","volume":"34","author":"MG Paggi","year":"1990","unstructured":"Paggi MG, Fanciulli M, Del Carlo C, Citro G, Carapella CM, Floridi A (1990) The membrane-bound hexokinase as a potential marker for malignancy in human gliomas. J Neurosurg Sci 34:209\u2013213","journal-title":"J Neurosurg Sci"},{"key":"7923_CR24","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2967\/jnmt.119.236109","volume":"48","author":"I Sarikaya","year":"2020","unstructured":"Sarikaya I, Sarikaya A (2020) Assessing PET parameters in oncologic (18)F-FDG studies. J Nucl Med Technol 48:278\u2013282","journal-title":"J Nucl Med Technol"},{"key":"7923_CR25","doi-asserted-by":"publisher","first-page":"222","DOI":"10.2967\/jnmt.115.161745","volume":"43","author":"G Akamatsu","year":"2015","unstructured":"Akamatsu G, Ikari Y, Nishida H et al (2015) Influence of statistical fluctuation on reproducibility and accuracy of SUVmax and SUVpeak: a phantom study. J Nucl Med Technol 43:222\u2013226","journal-title":"J Nucl Med Technol"},{"key":"7923_CR26","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1097\/RLU.0b013e318251e16e","volume":"37","author":"CC Chang","year":"2012","unstructured":"Chang CC, Cho SF, Chen YW, Tu HP, Lin CY, Chang CS (2012) SUV on dual-phase FDG PET\/CT correlates with the Ki-67 proliferation index in patients with newly diagnosed non-Hodgkin lymphoma. Clin Nucl Med 37:e189\u2013e195","journal-title":"Clin Nucl Med"},{"key":"7923_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.semnuclmed.2017.09.005","volume":"48","author":"L Kostakoglu","year":"2018","unstructured":"Kostakoglu L, Chauvie S (2018) Metabolic tumor volume metrics in lymphoma. Semin Nucl Med 48:50\u201366","journal-title":"Semin Nucl Med"},{"key":"7923_CR28","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1245\/s10434-009-0719-7","volume":"17","author":"SH Hyun","year":"2010","unstructured":"Hyun SH, Choi JY, Shim YM et al (2010) Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with esophageal carcinoma. Ann Surg Oncol 17:115\u2013122","journal-title":"Ann Surg Oncol"},{"key":"7923_CR29","doi-asserted-by":"publisher","first-page":"898","DOI":"10.2967\/jnumed.113.131847","volume":"55","author":"JW Lee","year":"2014","unstructured":"Lee JW, Kang CM, Choi HJ et al (2014) Prognostic value of metabolic tumor volume and total lesion glycolysis on preoperative (1)(8)F-FDG PET\/CT in patients with pancreatic cancer. J Nucl Med 55:898\u2013904","journal-title":"J Nucl Med"},{"key":"7923_CR30","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12967-018-1475-x","volume":"16","author":"Y Ikeno","year":"2018","unstructured":"Ikeno Y, Seo S, Iwaisako K et al (2018) Preoperative metabolic tumor volume of intrahepatic cholangiocarcinoma measured by (18)F-FDG-PET is associated with the KRAS mutation status and prognosis. J Transl Med 16:95","journal-title":"J Transl Med"},{"key":"7923_CR31","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.ejso.2011.06.008","volume":"37","author":"A Lazaryan","year":"2011","unstructured":"Lazaryan A, Kalmadi S, Almhanna K, Pelley R, Kim R (2011) Predictors of clinical outcomes of resected ampullary adenocarcinoma: a single-institution experience. Eur J Surg Oncol 37:791\u2013797","journal-title":"Eur J Surg Oncol"},{"key":"7923_CR32","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1245\/s10434-006-9136-3","volume":"14","author":"HP Hsu","year":"2007","unstructured":"Hsu HP, Yang TM, Hsieh YH, Shan YS, Lin PW (2007) Predictors for patterns of failure after pancreaticoduodenectomy in ampullary cancer. Ann Surg Oncol 14:50\u201360","journal-title":"Ann Surg Oncol"},{"key":"7923_CR33","doi-asserted-by":"publisher","first-page":"12676","DOI":"10.1038\/s41598-019-49179-w","volume":"9","author":"C Zimmermann","year":"2019","unstructured":"Zimmermann C, Wolk S, Aust DE et al (2019) The pathohistological subtype strongly predicts survival in patients with ampullary carcinoma. Sci Rep 9:12676","journal-title":"Sci Rep"},{"key":"7923_CR34","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1002\/jso.24274","volume":"114","author":"E Asano","year":"2016","unstructured":"Asano E, Okano K, Oshima M et al (2016) Phenotypic characterization and clinical outcome in ampullary adenocarcinoma. J Surg Oncol 114:119\u2013127","journal-title":"J Surg Oncol"},{"key":"7923_CR35","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/PAS.0000000000000230","volume":"38","author":"DC Ang","year":"2014","unstructured":"Ang DC, Shia J, Tang LH, Katabi N, Klimstra DS (2014) The utility of immunohistochemistry in subtyping adenocarcinoma of the ampulla of vater. Am J Surg Pathol 38:1371\u20131379","journal-title":"Am J Surg Pathol"},{"key":"7923_CR36","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1097\/MPA.0000000000000929","volume":"46","author":"M Feretis","year":"2017","unstructured":"Feretis M, Wang T, Iype S et al (2017) Development of a prognostic model that predicts survival after pancreaticoduodenectomy for ampullary cancer. Pancreas 46:1314\u20131321","journal-title":"Pancreas"},{"key":"7923_CR37","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1097\/00000478-200407000-00005","volume":"28","author":"H Zhou","year":"2004","unstructured":"Zhou H, Schaefer N, Wolff M, Fischer HP (2004) Carcinoma of the ampulla of Vater: comparative histologic\/immunohistochemical classification and follow-up. Am J Surg Pathol 28:875\u2013882","journal-title":"Am J Surg Pathol"},{"key":"7923_CR38","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s13304-013-0205-4","volume":"65","author":"P Raj","year":"2013","unstructured":"Raj P, Kaman L, Singh R, Dahyia D, Bhattacharya A, Bal A (2013) Sensitivity and specificity of FDG PET-CT scan in detecting lymph node metastasis in operable periampullary tumours in correlation with the final histopathology after curative surgery. Updates Surg 65:103\u2013107","journal-title":"Updates Surg"},{"key":"7923_CR39","first-page":"1551","volume":"42","author":"T Mochizuki","year":"2001","unstructured":"Mochizuki T, Tsukamoto E, Kuge Y et al (2001) FDG uptake and glucose transporter subtype expressions in experimental tumor and inflammation models. J Nucl Med 42:1551\u20131555","journal-title":"J Nucl Med"},{"key":"7923_CR40","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.semradonc.2013.11.001","volume":"24","author":"SK Jabbour","year":"2014","unstructured":"Jabbour SK, Mulvihill D (2014) Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol 24:85\u201393","journal-title":"Semin Radiat Oncol"},{"key":"7923_CR41","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1002\/cncr.10831","volume":"95","author":"T Takada","year":"2002","unstructured":"Takada T, Amano H, Yasuda H et al (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95:1685\u20131695","journal-title":"Cancer"},{"key":"7923_CR42","first-page":"362","volume":"12","author":"R Kim","year":"2011","unstructured":"Kim R, Chabot J, Saif MW (2011) Adjuvant treatment for ampullary cancer. Highlights from the \u201c2011 ASCO Annual Meeting\u201d. Chicago, IL, USA; June 3-7, 2011. JOP 12:362\u2013363","journal-title":"JOP"},{"key":"7923_CR43","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1001\/jamasurg.2019.1170","volume":"154","author":"BL Ecker","year":"2019","unstructured":"Ecker BL, Vollmer CM Jr, Behrman SW et al (2019) Role of adjuvant multimodality therapy after curative-intent resection of ampullary carcinoma. JAMA Surg 154:706\u2013714","journal-title":"JAMA Surg"},{"key":"7923_CR44","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/SLA.0000000000003177","volume":"272","author":"AL Moekotte","year":"2020","unstructured":"Moekotte AL, Lof S, Van Roessel S et al (2020) Histopathologic predictors of survival and recurrence in resected ampullary adenocarcinoma: International Multicenter Cohort Study. Ann Surg 272:1086\u20131093","journal-title":"Ann Surg"},{"key":"7923_CR45","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1001\/jama.2012.7352","volume":"308","author":"JP Neoptolemos","year":"2012","unstructured":"Neoptolemos JP, Moore MJ, Cox TF et al (2012) Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA 308:147\u2013156","journal-title":"JAMA"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-021-07923-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-021-07923-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,20]],"date-time":"2021-09-20T20:36:02Z","timestamp":1632170162000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-021-07923-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,17]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["7923"],"URL":"https:\/\/doi.org\/10.1007\/s00330-021-07923-9","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,17]]},"assertion":[{"value":"5 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The scientific guarantor of this publication is Ruoh-Fang Yen, Director of Department of Nuclear Medicine, National Taiwan University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"One of the authors has significant statistical expertise. Also, the Center of Statistical Consultation and Research in the Department of Medical Research of National Taiwan University Hospital kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This study was approved by the Institutional Review Board of National Taiwan University (No. 201212105MIND and 200705023R).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 prospective\u2022 diagnostic or prognostic study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}